Psilocybin and Psychedelics in New Jersey: Pending Legislation
This page tracks the current legal status of psilocybin, psychedelics, and entheogens in New Jersey. Status is updated from our legislation sync, with citations to the underlying bills and policy decisions.
Governor Murphy signed S2283 (Psilocybin Behavioral Health Access and Services Act) into law on January 20, 2026, establishing a Psilocybin Behavioral Health Access and Therapy Pilot Program with $6 million in funding. The pilot program operates under the Department of Health for clinical research and therapeutic access.
Governor Murphy signed S2283 on January 20, 2026 Establishes Psilocybin Behavioral Health Access and Therapy Pilot Program Appropriates $6 million in state funding for the program Program housed under New Jersey Department of Health Focus on clinical research and supervised therapeutic access Builds on years of legislative effort in the state
Laws change. Always verify current status with primary sources before acting on this information, especially when traveling across state lines.